Current Problems in Cardiology
Volume 32, Issue 5 , Pages 268-314 , May 2007

HDL Cholesterol: Physiology, Pathophysiology, and Management

  • Jeffrey J. Link, MD

      Affiliations

    • Dr. Link and Dr. Rohatgi have no conflict of interest to disclose.
    • ,
  • Anand Rohatgi, MD

      Affiliations

    • Dr. Link and Dr. Rohatgi have no conflict of interest to disclose.
    • ,
  • James A. de Lemos, MD

      Affiliations

    • Dr. de Lemos has received lecture honoraria from Merck/Schering and Pfizer and consulting fees from Pfizer.
    • Corresponding Author InformationAddress reprint requests to: James A. de Lemos, MD, UT Southwestern Medical Center, 5909 Harry Hines Blvd., HA 9.133, Dallas, TX 75390-9047.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0146-2806(07)00005-9

doi: 10.1016/j.cpcardiol.2007.01.004

Current Problems in Cardiology
Volume 32, Issue 5 , Pages 268-314 , May 2007

Article Tools

* Image Usage & Resolution